↓ Skip to main content

Does MIDAS reduction at 3 months predict the outcome of erenumab treatment? A real-world, open-label trial

Overview of attention for article published in The Journal of Headache and Pain, September 2022
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
21 Mendeley